Acadian Asset Management
CTXR icon

Acadian Asset Management’s Citius Pharmaceuticals CTXR Stock Holding History

Acadian Asset Management’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-289
Closed -$10K – 1855
2019
Q1 		$10K Buy
+289
New +$8.51K ﹤0.01% 1860

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAAM
Baker Avenue Asset Management San Francisco, California $4.43B AUM 26.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Acadian Asset Management's CTXR Position: Q2 2019 in Review

Acadian Asset Management sold out of Citius Pharmaceuticals (CTXR) in Q2 2019, closing a stake of 289 shares — an estimated $10K sold.

Acadian Asset Management first reported a position in CTXR in Q1 2019 and held it in 1 quarter. The position peaked at $10K in Q1 2019. 10 funds tracked by Wall St. Rank hold CTXR as of Q2 2019.

  • Acadian Asset Management reported no remaining Citius Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Acadian Asset Management sold 289 Citius Pharmaceuticals shares in Q2 2019, an estimated $10K.
  • Acadian Asset Management first reported a position in Citius Pharmaceuticals in Q1 2019 and held it in 1 quarter.
  • Acadian Asset Management's Citius Pharmaceuticals position peaked at $10K in Q1 2019.
  • 10 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2019.

Based on Acadian Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.